3
Announcements
Trials
Browse
Landscape
Status
Completed
117
Recruiting
96
Terminated
57
Active not recruiting
38
Unknown
30
Not yet recruiting
24
Withdrawn
17
Suspended
5
Approved for marketing
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
ivosidenib
1
gilteritinib
1
cc-486
1
Gemtuzumab
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Approved for marketing
×
Leukemia, Myeloid, Acute
×
Azacitidine
×
Clear all
NCT03723135
2020-09-18
Expanded Access for CC-486
Celgene
Approved for marketing